Richard Åhlberg

Richard Åhlberg

Director/Board Member at Genagon Therapeutics AB

Health Technology
Finance
Technology Services

Profile

Richard Åhlberg is currently a Director at Genagon Therapeutics AB, a Director at Doktorse Nordic AB, and an Advisor at Beijer Ventures AB.
He was previously a Director at Moleculink AB from 2016 to 2022, a Business Unit Director at Roche AB, a Director at Olink Proteomics AB from 2017 to 2019, and a Business Director at Aleris Healthcare AB from 2006 to 2011.
Dr. Åhlberg received his graduate and doctorate degrees from Karolinska Institutet in 1986 and 1993, respectively.

Richard Åhlberg active positions

CompaniesPositionStart
Director/Board Member -
Consultant / Advisor -
Director/Board Member 31/12/2016
All active positions of Richard Åhlberg

Former positions of Richard Åhlberg

CompaniesPositionEnd
Director/Board Member 30/12/2022
Director/Board Member 30/12/2019
Corporate Officer/Principal 30/12/2011
Corporate Officer/Principal -
See the detail of Richard Åhlberg's experience

Training of Richard Åhlberg

Karolinska Institutet Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Åhlberg's experience

Connections

49

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies7

Health Technology

Finance

Technology Services

Electronic Technology

Commercial Services

Health Services

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Richard Åhlberg